These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 27393115)

  • 21. Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement.
    Albanese A; Abbruzzese G; Dressler D; Duzynski W; Khatkova S; Marti MJ; Mir P; Montecucco C; Moro E; Pinter M; Relja M; Roze E; Skogseid IM; Timerbaeva S; Tzoulis C
    J Neurol; 2015 Oct; 262(10):2201-13. PubMed ID: 25877834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reply: Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: randomized, double-blind, noninferiority trial.
    Mueller J
    Mov Disord; 2009 May; 24(7):1098-9; author reply 1100. PubMed ID: 18942082
    [No Abstract]   [Full Text] [Related]  

  • 23. When the levator scapulae becomes a "rotator capitis": implications for cervical dystonia.
    Erro R; Bhatia KP; Catania S; Shields K; Cordivari C
    Parkinsonism Relat Disord; 2013 Jul; 19(7):705-6. PubMed ID: 23611686
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of botulinum toxin injections for spasmodic torticollis of tardive dystonia.
    Kaufman DM
    J Neuropsychiatry Clin Neurosci; 1994; 6(1):50-3. PubMed ID: 8148637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.
    Brin MF; Fahn S; Moskowitz C; Friedman A; Shale HM; Greene PE; Blitzer A; List T; Lange D; Lovelace RE
    Adv Neurol; 1988; 50():599-608. PubMed ID: 3400513
    [No Abstract]   [Full Text] [Related]  

  • 27. Duration of effectiveness of botulinum toxin type B in the treatment of cervical dystonia.
    Lew MF
    Adv Neurol; 2004; 94():211-5. PubMed ID: 14509675
    [No Abstract]   [Full Text] [Related]  

  • 28. Collum-caput (COL-CAP) concept for conceptual anterocollis, anterocaput, and forward sagittal shift.
    Finsterer J; Maeztu C; Revuelta GJ; Reichel G; Truong D
    J Neurol Sci; 2015 Aug; 355(1-2):37-43. PubMed ID: 26088286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The position of the head in space: a kinematic analysis in patients with cervical dystonia treated with botulinum toxin.
    Albani G; Bulgheroni MV; Mancini F; Mauro A; Fundarò C; Pacchetti C; Sandrini G; Nappi G
    Funct Neurol; 2001; 16(2):135-41. PubMed ID: 11495419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical features of the geste antagoniste in cervical dystonia.
    Filipović SR; Jahanshahi M; Viswanathan R; Heywood P; Rogers D; Bhatia KP
    Adv Neurol; 2004; 94():191-201. PubMed ID: 14509673
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical uses of botulinum neurotoxins: current indications, limitations and future developments.
    Chen S
    Toxins (Basel); 2012 Oct; 4(10):913-39. PubMed ID: 23162705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The phenomenology of cervical dystonia].
    Reichel G; Stenner A; Jahn A
    Fortschr Neurol Psychiatr; 2009 May; 77(5):272-7. PubMed ID: 19418385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cervical dystonia treatment with botulin toxin].
    Tomczykiewicz K
    Pol Merkur Lekarski; 2016 Aug; 41(242):107-10. PubMed ID: 27591450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensory tricks and brain excitability in cervical dystonia: a transcranial magnetic stimulation study.
    Amadio S; Houdayer E; Bianchi F; Tesfaghebriel Tekle H; Urban IP; Butera C; Guerriero R; Cursi M; Leocani L; Comi G; Del Carro U
    Mov Disord; 2014 Aug; 29(9):1185-8. PubMed ID: 24753013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anterocollis: clinical features and treatment options.
    Papapetropoulos S; Tuchman A; Sengun C; Russell A; Mitsi G; Singer C
    Med Sci Monit; 2008 Sep; 14(9):CR427-30. PubMed ID: 18758411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dystonia and headaches: clinical features and response to botulinum toxin therapy.
    Galvez-Jimenez N; Lampuri C; Patiño-Picirrillo R; Hargreave MJ; Hanson MR
    Adv Neurol; 2004; 94():321-8. PubMed ID: 14509690
    [No Abstract]   [Full Text] [Related]  

  • 37. Craniocervical dystonia: clinical and pathophysiological features.
    Colosimo C; Suppa A; Fabbrini G; Bologna M; Berardelli A
    Eur J Neurol; 2010 Jul; 17 Suppl 1():15-21. PubMed ID: 20590803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of cervical dystonia with botulinum toxins.
    Comella CL; Thompson PD
    Eur J Neurol; 2006 Feb; 13 Suppl 1():16-20. PubMed ID: 16417593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of botulinum toxin in the treatment of cervical dystonia.
    Poewe W; Wissel J
    Baillieres Clin Neurol; 1993 Apr; 2(1):179-85. PubMed ID: 8143072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin enhancement of postoperative immobilization in patients with cervical dystonia. Technical note.
    Traynelis VC; Ryken T; Rodnitzky RL; Menezes AH
    J Neurosurg; 1992 Nov; 77(5):808-9. PubMed ID: 1403128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.